Indicator Explainer

PSA

Prostate-specific antigen — a prostate tissue protein whose blood level rises in prostate cancer and in common benign conditions.

Reviewed 2026-10-06
Read this first

This page explains what the indicator is and how results are interpreted in general terms. Reference ranges depend on the laboratory, the method, and your own situation — no single “normal value” applies to everyone. This page is health information, not a diagnosis. For symptoms, treatment, or urgent concerns, contact a healthcare professional.

When it is tested

Measured in shared-decision discussions about prostate cancer screening, in evaluation of urinary symptoms, and in monitoring after diagnosis or treatment.

Reading results

PSA is not cancer-specific: benign enlargement, inflammation, urinary retention, cycling, and recent procedures all raise it, and some prostate cancers do not raise it at all. Age-specific and assay-specific ranges differ, and a single value should never drive a diagnosis — trends, ratios (free-to-total), and clinical findings carry the decision. Screening involves documented harms and benefits and is a shared decision.

Questions to ask a professional

  • What could have transiently raised this value (cycling, infection, procedures)?
  • What is the trend against earlier values on the same assay?
  • What are the documented benefits and harms of further investigation at this level?